A detailed history of Biondo Investment Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Biondo Investment Advisors, LLC holds 905 shares of REGN stock, worth $678,306. This represents 0.13% of its overall portfolio holdings.

Number of Shares
905
Previous 905 -0.0%
Holding current value
$678,306
Previous $951,000 -0.0%
% of portfolio
0.13%
Previous 0.14%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$775.18 - $881.7 $38,759 - $44,085
50 Added 5.85%
905 $794,000
Q3 2023

Nov 09, 2023

SELL
$692.45 - $844.37 $103,867 - $126,655
-150 Reduced 14.93%
855 $703,000
Q1 2023

May 09, 2023

BUY
$680.49 - $826.97 $85,061 - $103,371
125 Added 14.2%
1,005 $825,000
Q4 2022

Feb 09, 2023

SELL
$705.89 - $766.39 $17,647 - $19,159
-25 Reduced 2.76%
880 $634,000
Q2 2022

Aug 11, 2022

SELL
$548.35 - $738.84 $184,793 - $248,989
-337 Reduced 27.13%
905 $535,000
Q1 2022

May 12, 2022

BUY
$595.12 - $698.43 $200,555 - $235,370
337 Added 37.24%
1,242 $867,000
Q3 2021

Nov 09, 2021

BUY
$574.03 - $680.96 $278,404 - $330,265
485 Added 115.48%
905 $548,000
Q2 2021

Aug 03, 2021

BUY
$472.8 - $558.54 $198,576 - $234,586
420 New
420 $235,000
Q4 2020

Feb 04, 2021

SELL
$478.3 - $607.98 $1.6 Million - $2.04 Million
-3,350 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$493.32 - $643.92 $1.65 Million - $2.16 Million
3,350 New
3,350 $2.09 Million
Q3 2019

Nov 05, 2019

SELL
$273.46 - $318.39 $287,133 - $334,309
-1,050 Closed
0 $0
Q2 2019

Aug 06, 2019

SELL
$299.6 - $414.82 $7.1 Million - $9.82 Million
-23,682 Reduced 95.75%
1,050 $329,000
Q1 2019

May 08, 2019

BUY
$372.08 - $439.57 $2.6 Million - $3.07 Million
6,980 Added 39.32%
24,732 $10.2 Million
Q4 2018

Feb 08, 2019

SELL
$335.82 - $403.04 $2.74 Million - $3.29 Million
-8,160 Reduced 31.49%
17,752 $6.63 Million
Q3 2018

Nov 07, 2018

BUY
$351.14 - $408.51 $3.18 Million - $3.71 Million
9,070 Added 53.85%
25,912 $10.5 Million
Q2 2018

Aug 02, 2018

BUY
$284.6 - $344.99 $116,116 - $140,755
408 Added 2.48%
16,842 $5.81 Million
Q1 2018

May 02, 2018

BUY
$315.82 - $393.78 $89,061 - $111,045
282 Added 1.75%
16,434 $5.66 Million
Q4 2017

Feb 07, 2018

SELL
$358.63 - $469.95 $26,179 - $34,306
-73 Reduced 0.45%
16,152 $6.07 Million
Q3 2017

Nov 08, 2017

BUY
$431.38 - $504.0 $7 Million - $8.18 Million
16,225
16,225 $7.26 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $80.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Biondo Investment Advisors, LLC Portfolio

Follow Biondo Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Biondo Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biondo Investment Advisors, LLC with notifications on news.